Cubist Systematic Strategies LLC raised its holdings in Colfax Corporation (NYSE:CFX) by 3,469.6% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 38,337 shares of the industrial products company’s stock after purchasing an additional 37,263 shares during the quarter. Cubist Systematic Strategies LLC’s holdings in Colfax Corporation were worth $1,509,000 at the end of the most recent reporting period.
A number of other large investors have also bought and sold shares of the business. Principal Financial Group Inc. boosted its holdings in Colfax Corporation by 1.1% in the second quarter. Principal Financial Group Inc. now owns 8,956,040 shares of the industrial products company’s stock valued at $352,600,000 after purchasing an additional 95,361 shares during the last quarter. Vanguard Group Inc. boosted its holdings in Colfax Corporation by 0.4% in the second quarter. Vanguard Group Inc. now owns 6,625,006 shares of the industrial products company’s stock valued at $260,827,000 after purchasing an additional 28,081 shares during the last quarter. FMR LLC boosted its holdings in Colfax Corporation by 32.8% in the first quarter. FMR LLC now owns 4,243,210 shares of the industrial products company’s stock valued at $166,588,000 after purchasing an additional 1,048,360 shares during the last quarter. BlackRock Inc. boosted its holdings in Colfax Corporation by 1.7% in the second quarter. BlackRock Inc. now owns 4,174,568 shares of the industrial products company’s stock valued at $164,353,000 after purchasing an additional 70,676 shares during the last quarter. Finally, Bares Capital Management Inc. boosted its holdings in Colfax Corporation by 1.2% in the first quarter. Bares Capital Management Inc. now owns 4,080,045 shares of the industrial products company’s stock valued at $160,183,000 after purchasing an additional 49,070 shares during the last quarter. 75.22% of the stock is currently owned by institutional investors.
Colfax Corporation (NYSE:CFX) traded up 0.26% on Thursday, hitting $42.14. 25,568 shares of the company traded hands. The stock has a market cap of $5.18 billion, a PE ratio of 33.15 and a beta of 1.32. The stock’s 50-day moving average is $40.95 and its 200 day moving average is $40.11. Colfax Corporation has a 12 month low of $28.47 and a 12 month high of $42.93.
Colfax Corporation (NYSE:CFX) last announced its quarterly earnings results on Friday, July 28th. The industrial products company reported $0.43 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.43. Colfax Corporation had a net margin of 4.35% and a return on equity of 6.30%. The company had revenue of $965.83 million for the quarter, compared to the consensus estimate of $940.31 million. During the same quarter in the prior year, the firm earned $0.41 earnings per share. The company’s revenue for the quarter was up .9% compared to the same quarter last year. Equities research analysts expect that Colfax Corporation will post $1.72 earnings per share for the current fiscal year.
In other Colfax Corporation news, SVP Stephen Wittig sold 29,189 shares of the company’s stock in a transaction dated Thursday, September 7th. The shares were sold at an average price of $39.30, for a total value of $1,147,127.70. Following the sale, the senior vice president now owns 15,479 shares of the company’s stock, valued at $608,324.70. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Daniel A. Pryor sold 3,574 shares of the company’s stock in a transaction dated Tuesday, August 1st. The shares were sold at an average price of $41.13, for a total transaction of $146,998.62. Following the completion of the sale, the executive vice president now directly owns 40,224 shares in the company, valued at approximately $1,654,413.12. The disclosure for this sale can be found here. Insiders sold 33,202 shares of company stock worth $1,312,182 in the last ninety days. Insiders own 10.60% of the company’s stock.
Several equities research analysts have commented on the stock. Citigroup Inc. reaffirmed a “sell” rating and issued a $40.00 price target (up from $39.00) on shares of Colfax Corporation in a report on Monday. Zacks Investment Research lowered shares of Colfax Corporation from a “buy” rating to a “hold” rating in a research note on Wednesday, August 2nd. Royal Bank Of Canada reissued a “buy” rating and set a $45.00 target price on shares of Colfax Corporation in a research note on Wednesday, September 27th. BidaskClub lowered shares of Colfax Corporation from a “hold” rating to a “sell” rating in a research note on Friday, August 18th. Finally, KeyCorp reissued a “buy” rating and set a $46.00 target price on shares of Colfax Corporation in a research note on Tuesday, September 26th. Two equities research analysts have rated the stock with a sell rating, four have issued a hold rating and nine have given a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus price target of $46.00.
Colfax Corporation Company Profile
Colfax Corporation is an industrial manufacturing and engineering company. The Company provides gas and fluid handling and fabrication technology products and services to customers around the world. The Company’s segments include Gas and Fluid Handling, and Fabrication Technology. The Gas and Fluid Handling segment supplies a range of gas and fluid handling products, including heavy-duty centrifugal and axial fans, rotary heat exchangers, gas compressors, pumps and certain related products, as well as aftermarket and lubrication-related services, which serves customers in the power generation, oil, gas and petrochemical, mining, marine (including defense) and general industrial and other end markets.
Want to see what other hedge funds are holding CFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colfax Corporation (NYSE:CFX).
What are top analysts saying about Colfax Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Colfax Corporation and related companies.